Latest period
$65.90M
YoY change
-31.8%
5Y CAGR
-20.7%
Peak year (2020)
$187.38M
Cumulative CapEx
$1.37B
CapEx history chart for Incyte (INCY) from 1993 to 2025
Latest: $58.87M
CapEx growth chart for Incyte (INCY) from 1993 to 2025
Latest: -31.8%
CapEx history table for Incyte (INCY) from 1993 to 2025
| 2025 | $58.87M | -31.8% | −$27.40M | ||
| 2024 | $86.26M | +81.7% | +$38.78M | ||
| 2023 | $47.49M | -39.0% | −$30.35M | ||
| 2022 | $77.83M | -57.0% | −$103.17M | ||
| 2021 | $181.01M | -3.4% | −$6.37M | ||
| 2020 | $187.38M | +140.0% | +$109.31M | ||
| 2019 | $78.06M | +6.2% | +$4.58M | ||
| 2018 | $73.48M | -33.8% | −$37.54M | ||
| 2017 | $111.02M | -7.7% | −$9.26M | ||
| 2016 | $120.28M | +362.6% | +$94.27M | ||
| 2015 | $26.00M | -6.7% | −$1.87M | ||
| 2014 | $27.88M | +553.3% | +$23.61M | ||
| 2013 | $4.27M | +50.3% | +$1.43M | ||
| 2012 | $2.84M | -25.3% | −$960.00K | ||
| 2011 | $3.80M | -7.5% | −$310.00K | ||
| 2010 | $4.11M | +961.8% | +$3.72M | ||
| 2009 | $387.00K | -44.6% | −$311.00K | ||
| 2008 | $698.00K | -39.5% | −$455.00K | ||
| 2007 | $1.15M | -26.5% | −$415.00K | ||
| 2006 | $1.57M | -4.0% | −$65.00K | ||
| 2005 | $1.63M | +17.4% | +$242.00K | ||
| 2004 | $1.39M | -85.7% | −$8.35M | ||
| 2003 | $9.74M | -18.1% | −$2.15M | ||
| 2002 | $11.89M | -8.0% | −$1.03M | ||
| 2001 | $12.92M | -86.6% | −$83.46M | ||
| 2000 | $96.38M | +176.9% | +$61.58M | ||
| 1999 | $34.80M | +0.3% | +$100.00K | ||
| 1998 | $34.70M | +33.0% | +$8.60M | ||
| 1997 | $26.10M | +29.2% | +$5.90M | ||
| 1996 | $20.20M | +155.7% | +$12.30M | ||
| 1995 | $7.90M | +203.8% | +$5.30M | ||
| 1994 | $2.60M | +550.0% | +$2.20M | ||
| 1993 | $400.00K | — | — |
- 2025$58.87M-31.8%
- 2024$86.26M+81.7%
- 2023$47.49M-39.0%
- 2022$77.83M-57.0%
- 2021$181.01M-3.4%
- 2020$187.38M+140.0%
- 2019$78.06M+6.2%
- 2018$73.48M-33.8%
- 2017$111.02M-7.7%
- 2016$120.28M+362.6%
- 2015$26.00M-6.7%
- 2014$27.88M+553.3%
- 2013$4.27M+50.3%
- 2012$2.84M-25.3%
- 2011$3.80M-7.5%
- 2010$4.11M+961.8%
- 2009$387.00K-44.6%
- 2008$698.00K-39.5%
- 2007$1.15M-26.5%
- 2006$1.57M-4.0%
- 2005$1.63M+17.4%
- 2004$1.39M-85.7%
- 2003$9.74M-18.1%
- 2002$11.89M-8.0%
- 2001$12.92M-86.6%
- 2000$96.38M+176.9%
- 1999$34.80M+0.3%
- 1998$34.70M+33.0%
- 1997$26.10M+29.2%
- 1996$20.20M+155.7%
- 1995$7.90M+203.8%
- 1994$2.60M+550.0%
- 1993$400.00K—
CapEx values are taken from Incyte's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current CapEx (TTM) is $65.90M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Incyte (INCY) CapEx is $58.87M – plunged 31.8% year-over-year.
Over 2020–2025 (5 years), Incyte CapEx expanded at a -20.7% compound annual rate, with a net decline across the window.
Incyte CapEx peaked at $187.38M in 2020; the latest annual figure is $58.87M in 2025 (68.6% below peak).
The highest annual CapEx of $187.38M was reported in 2020. The lowest in the available history was $387.00K in 2009.
Incyte Capital Expenditures by Year
Incyte Capital Expenditures 2025: $58.87M
Incyte posted CapEx of $58.87M in 2025, plunged 31.8% below 2024.
Incyte Capital Expenditures 2024: $86.26M
In 2024, Incyte reported CapEx of $86.26M, surged 81.7% from 2023.
Incyte Capital Expenditures 2023: $47.49M
Incyte CapEx in 2023 was $47.49M, plunged 39.0% below 2022.
Incyte Capital Expenditures 2022: $77.83M
2022's CapEx for Incyte came in at $77.83M, plunged 57.0% below 2021.
Incyte Capital Expenditures 2021: $181.01M
Incyte CapEx in 2021 was $181.01M.
See more financial history for Incyte (INCY).
Sector peers by CapEx
Healthcare peers of Incyte (INCY), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation